Seminars in Pediatric Neurology
Volume 15, Issue 3 , Pages 110-116 , September 2008

A Review of Newborn Screening in the Era of Tandem Mass Spectrometry: What's New for the Pediatric Neurologist?

  • Sara Copeland, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Sara Copeland, MD, University of Iowa Children's Hospital, 200 Hawkins Drive W133GH, Iowa City, IA 52242

References 

  1. Paul DB. Patient advocacy in newborn screening: Continuities and discontinuities. Am J Med Genet C Semin Med Genet. 2008;148:8–14
  2. Millington DS, Kodo N, Norwood DL, et al. Tandem mass spectrometry: A new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis. 1990;13:321–324
  3. American College of Medical Genetics Newborn Screening Expert Group. Newborn screening: Toward a uniform screening panel and system–executive summary. Pediatrics. 2006;117:S296–S307
  4. National Newborn Screening Status Report, 2008. http://genes-r-us.uthscsa.edu/nbsdisorders.htmAccessed March 1, 2008
  5. American Academy of Pediatrics Newborn Screening Authoring Committee. Newborn screening expands: Recommendations for pediatricians and medical homes—Implications for the system. Pediatrics. 2008;121:192–217
  6. Lee B, Goss J. Long-term correction of urea cycle disorders. J Pediatr. 2001;138(suppl):S62–S71
  7. Bachmann C. Outcome and survival of 88 patients with urea cycle disorders: A retrospective evaluation. Eur J Pediatr. 2003;162:410–416
  8. Seashore MR. The organic acidemias: An overview. http://www.geneclinics.org/servlet/access?db=geneclinics&site=gt&id=8888891&key=hMo4g4tq34Ndv&gry=&fcn=y&fw=rblh&filename=/profiles/mma/index.htmlAccessed March 1, 2008
  9. Brivet M, Boutron A, Slama A, et al. Defects in activation and transport of fatty acids. J Inherit Metab Dis. 1999;22:428–441
  10. Bartlett K, Eaton S. Mitochondrial beta-oxidation. Eur J Biochem. 2004;271:462–469
  11. Bok LA, Vreken P, Wijburg FA, et al. Short-chain Acyl-CoA dehydrogenase deficiency: Studies in a large family adding to the complexity of the disorder. Pediatrics. 2003;112:1152–1155
  12. Vatanavicharn N, Pressman BD, Wilcox WR. Reversible leukoencephalopathy with acute neurological deterioration and permanent residua in classical homocystinuria: A case report. J Inherit Metab Dis. 2008;Jan 22 [Epub ahead of print]
  13. Sener RN. Brain magnetic resonance imaging in tyrosinemia. Acta Radiol. 2005;46:618–620
  14. Oregon Department of Human Services NBS expanded panel Fact Sheets. http//www.oregon.gov/DHS/ph/nbs/expand.shtmlAccessed March 1, 2008
  15. Vermathen P, Robert-Tissot L, Pietz J, et al. Characterization of white matter alterations in phenylketonuria by magnetic resonance relaxometry and diffusion tensor imaging. Magn Reson Med. 2007;58:1145–1156
  16. Wong YC, Au WL, Xu M, et al. Magnetic resonance spectroscopy in adult-onset citrullinemia: Elevated glutamine levels in comatose patients. Arch Neurol. 2007;64:1034–1037
  17. Scaglia F, Lee B. Clinical, biochemical, and molecular spectrum of hyperargininemia due to arginase I deficiency. Am J Med Genet C Semin Med Genet. 2006;142:113–120
  18. Squires L, Betz B, Umfleet J, et al. Resolution of subependymal cysts in neonatal holocarboxylase synthetase deficiency. Dev Med Child Neurol. 1997;39:267–269
  19. Chien YH, Peng SF, Wang TR, et al. Cranial MR spectroscopy of tetrahydrobiopterin deficiency. AJNR Am J Neuroradiol. 2002;23:1055–1058
  20. OMIM database METHIONINE ADENOSYLTRANSFERASE DEFICIENCY. www.ncbi.nlm.nih.gov/entrez/dispomim.cgi?id=250850Accessed March 1, 2008
  21. Longo D, Fariello G, Dionisi-Vici C, et al. MRI and 1H-MRS findings in early-onset cobalamin C/D defect. Neuropedatrics. 2005;36:366–372
  22. Friedman JH, Levy HL, Boustany RM. Late onset of distinct neurologic syndromes in galactosemic siblings. Neurology. 1989;39:741–742
  23. Schweitzer-Krantz S. Early diagnosis of inherited metabolic disorders towards improving outcome: The controversial issue of galactosaemia. Eur J Pediatr. 2003;162(suppl 1):S50–S53
  24. Ma T, Lian ZC, Qi SP, et al. Magnetic resonance imaging of brain and the neuromotor disorder in endemic cretinism. Ann Neurol. 1993;34:91–94
  25. Büyükgebiz A. Congenital hypothyroidism clinical aspects and late consequences. Pediatr Endocrinol Rev. 2003;1(suppl 2):185–190
  26. Wasniewska M, De Luca F, Siclari S, et al. Hearing loss in congenital hypothalamic hypothyroidism: A wide therapeutic window. Hear Res. 2002;172:87–91
  27. Saito Y, Ogawa T, Nagaishi J, et al. Laminar cortical necrosis in adrenal crisis: Sequential changes on MRI. Brain Dev. 2008;30:77–81
  28. Merke DP, Bornstein SR, Avila NA, et al. NIH conference (Future directions in the study and management of congenital adrenal hyperplasia due to 21-hydroxylase deficiency). Ann Intern Med. 2002;136:320–334
  29. Chabre O, Portrat-Doyen S, Chaffanjon P, et al. Bilateral laparoscopic adrenalectomy for congenital adrenal hyperplasia with severe hypertension, resulting from two novel mutations in splice donor sites of CYP11B1. J Clin Endocrinol Metab. 2000;85:4060–4068
  30. Smiley D, Dagogo-Jack S, Umpierrez G. Therapy insight: metabolic and endocrine disorders in sickle cell disease. Nat Clin Pract Endocrinol Metab. 2008;4:102–109
  31. Shaligram D, Girimaji SC, Chaturvedi SK. Psychological problems and quality of life in children with thalassemia. Indian J Pediatr. 2007;74:727–730
  32. Jovanovic-Bateman L, Hedreville R. Sensorineural hearing loss with brainstem auditory evoked responses changes in homozygote and heterozygote sickle cell patients in Guadeloupe (France). J Laryngol Otol. 2006;120:627–630
  33. Sawaya RA, Zahed L, Taher A. Peripheral neuropathy in thalassaemia. Ann Saudi Med. 2006;26:358–363
  34. Taher A, Bashshur Z, Shamseddeen WA, et al. Ocular findings among thalassemia patients. Am J Ophthalmol. 2006;142:704–705

PII: S1071-9091(08)00046-6

doi: 10.1016/j.spen.2008.05.003

Seminars in Pediatric Neurology
Volume 15, Issue 3 , Pages 110-116 , September 2008

Article Tools